CAMBRIDGE, England--(BUSINESS WIRE)--Mursla, a novel multi-omics exosome characterisation company, is pleased to present its novel nanochip-based technology, as detailed in the pre-print* ‘An ...
Figure 1. EC-purified MCF-7-derived exosomes were stained with ExoBrite™ CD9 560/585 Flow Antibody (left). Specific staining was seen, compared with the same antibody in buffer (right). Exosomes were ...
Cancer, a leading cause of death globally, releases TDEs, tiny vesicles containing crucial bioactive components. These exosomes play key roles in cell communication and cancer progression. Current ...
SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine ...
Liquid biopsy, a noninvasive method used for analysis of circulating biomarkers like tumor cells, DNA, and exosomes from bodily fluids, shows promise in advancing cancer research for future diagnostic ...
Working principle of the constructed μFMS for on-chip TDE capture and detection. a DNA TSPs immobilized on aldehyde-functionalized glass slides via covalent coupling between amine and aldehyde groups.
Extracellular vesicles (EVs) are small, membrane-bound particles secreted from cells and thought to function as cellular messengers, carrying cargo from one cell to another. In biomedical research, ...
SAN DIEGO – An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the ...
Please provide your email address to receive an email when new articles are posted on . The blood test reliably detected patients with stage I and II pancreatic ductal adenocarcinoma with 97% accuracy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results